Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cue Biopharma Inc (NQ: CUE ) 1.780 +0.130 (+7.88%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Cue Biopharma Inc < Previous 1 2 3 Next > 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session October 11, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session October 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 09, 2024 Via Benzinga Forecasting The Future: 4 Analyst Projections For Cue Biopharma April 09, 2024 Via Benzinga Where Cue Biopharma Stands With Analysts June 15, 2023 Via Benzinga Cue Biopharma Earnings Perspective: Return On Capital Employed March 22, 2023 Via Benzinga Cue Biopharma's Earnings Outlook March 20, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session October 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session October 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session October 03, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session September 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 27, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session September 26, 2024 Via Benzinga CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q2 2024 August 15, 2024 CUE stock results show that Cue Biopharma beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Medical Moonshots: 3 Biotech Stocks Set to Skyrocket May 30, 2024 Though risky, investors who buy biotech stocks watch their portfolios skyrocket when their drugs work as intended. Via InvestorPlace CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q1 2024 May 09, 2024 CUE stock results show that Cue Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session May 02, 2024 Via Benzinga CUE Stock Earnings: Cue Biopharma Misses EPS, Beats Revenue for Q4 2023 April 02, 2024 CUE stock results show that Cue Biopharma missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session January 01, 2024 Via Benzinga CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q3 2023 December 14, 2023 CUE stock results show that Cue Biopharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023. Via InvestorPlace Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 13, 2024 Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24... Via Benzinga The Truth About IPO Investing September 02, 2023 When most companies go public, they are somewhat mature. Tech company initial public offerings, or IPOs, are a bit different, however. These companies are often not yet profitable. And biotech IPOs are... Via Talk Markets Topics Initial Public Offering Exposures Securities Market Cue Biopharma And 2 Other Stocks Under $3 Insiders Are Buying August 30, 2023 The Dow Jones closed higher by close to 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities 3 Biotech Stocks to Buy as Companies Ink Major Deals June 22, 2023 Pharmaceutical and biotech companies will soon face generic competition, creating big opportunity for these top biotech stocks to buy. Via InvestorPlace 3 Biotech Stocks Sitting on Huge-Upside Catalysts May 26, 2023 The biotech boom is hot. According to Grand View, it could be worth $2.44 trillion. It's why we have an eye on these top biotech stocks. Via InvestorPlace 7 Hot Growth Stocks Poised to Triple in 2023 May 05, 2023 These hot growth stocks to buy can triple in price in 2023, with some holding impressive upside that's much higher. Via InvestorPlace 7 High-Potential Penny Stocks in the Biotech Sector May 04, 2023 Most of the biggest biotech stocks on the market started off as unknown penny stocks. Here are seven hot ones to consider. Via InvestorPlace Earnings Scheduled For March 21, 2023 March 21, 2023 Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
